In a preclinical study, inhibition of VEGF caused transient vascular normalization, leading to reduced tumor hypoxia and increased immune cell infiltration, which may result in increased antitumor immunity.22, 23, 24 On the basis of these findings, ICIs plus VEGF inhibitors are considered effective combination treatment options. The gene discussed is VEGFA; the disease is neoplasm.